While anti-neoplastic effects and survival benefits using angiogenesis inhibitors such as targeting the VEGF signaling pathway are often evident, relapse to progressive tumor growth typically ensues, reflecting multiple pro-angiogenic mechanisms of adaptation (36). The gene discussed is VEGFA; the disease is neoplasm.